Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

High circulating tumor cell (CTC) counts are associated with poor prognosis in advanced prostate cancer, and recently CTC number was suggested to be a surrogate for survival in metastatic castrate-resistant prostate cancer (mCRPC).